Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers? | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

Correspondence

Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?

Free

Authors

Gerasimos Evangelatos Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece PubMed articles Google scholar articles
George E Fragoulis Rheumatology Unit, First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece PubMed articles Google scholar articles
Alexios Iliopoulos Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece PubMed articles Google scholar articles

Correspondence to Dr Gerasimos Evangelatos, Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), 115 21 Athens, Greece; gerevag{at}gmail.com

Citation

Evangelatos G, Fragoulis GE, Iliopoulos A

Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?

Annals of the Rheumatic Diseases 2021;80:e184.

Publication history

Received October 23, 2019
Accepted October 30, 2019
First published November 5, 2019.

Online issue publication

January 27, 2022

Article Versions

Previous version (8 January 2022).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.